Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation
Authors
Keywords
Glioblastoma, Perfusion weighted magnetic resonance imaging, rCBV, Biomarker, Radiotherapy
Journal
EUROPEAN RADIOLOGY
Volume 26, Issue 11, Pages 4194-4203
Publisher
Springer Nature
Online
2016-02-03
DOI
10.1007/s00330-016-4234-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma
- (2015) Marta Scorsetti et al. BMC CANCER
- Perfusion MRI in the Evaluation of Suspected Glioblastoma Recurrence
- (2015) Stella Blasel et al. JOURNAL OF NEUROIMAGING
- Imaging of gliomas at 1.5 and 3 Tesla - A comparative study
- (2014) L. Tselikas et al. NEURO-ONCOLOGY
- Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide in Glioblastoma Patients: Application of Dynamic Susceptibility Contrast Perfusion and Diffusion-Weighted Imaging
- (2014) Jae Hyun Kim et al. PLoS One
- Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma
- (2013) B. M. Ellingson et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Prediction of Pseudoprogression in Patients with Glioblastomas Using the Initial and Final Area Under the Curves Ratio Derived from Dynamic Contrast-Enhanced T1-Weighted Perfusion MR Imaging
- (2013) C.H. Suh et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- True Progression versus Pseudoprogression in the Treatment of Glioblastomas: A Comparison Study of Normalized Cerebral Blood Volume and Apparent Diffusion Coefficient by Histogram Analysis
- (2013) Yong Sub Song et al. KOREAN JOURNAL OF RADIOLOGY
- Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Radiation Therapy and Concomitant Temozolomide: Comparison Study of Standard and High-b-Value Diffusion-weighted Imaging
- (2013) Hee Ho Chu et al. RADIOLOGY
- Volumetric and MGMT parameters in glioblastoma patients: Survival analysis
- (2012) Georgios Iliadis et al. BMC CANCER
- MRI perfusion in determining pseudoprogression in patients with glioblastoma
- (2012) Robert J. Young et al. CLINICAL IMAGING
- Evaluation of Intra- and Interfraction Movement of the Cervix and the Uterine Body During Intensity Modulated Radiation Therapy
- (2012) Q. Wang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Perfusion magnetic resonance imaging: Comparison of semiologic characteristics in first-pass perfusion of brain tumors at 1.5 and 3 Tesla
- (2012) Natacha Mauz et al. JOURNAL OF NEURORADIOLOGY
- Standards of care for treatment of recurrent glioblastoma—are we there yet?
- (2012) Michael Weller et al. NEURO-ONCOLOGY
- Diagnostic Dilemma of Pseudoprogression in the Treatment of Newly Diagnosed Glioblastomas: The Role of Assessing Relative Cerebral Blood Flow Volume and Oxygen-6-Methylguanine-DNA Methyltransferase Promoter Methylation Status
- (2011) D.-S. Kong et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- The Added Value of Apparent Diffusion Coefficient to Cerebral Blood Volume in the Preoperative Grading of Diffuse Gliomas
- (2011) A. Hilario et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: Assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI
- (2010) Yong Hwy Kim et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Parametric Response Map As an Imaging Biomarker to Distinguish Progression From Pseudoprogression in High-Grade Glioma
- (2010) Christina Tsien et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Changes in Relative Cerebral Blood Volume 1 Month after Radiation-Temozolomide Therapy Can Help Predict Overall Survival in Patients with Glioblastoma
- (2010) Rajiv Mangla et al. RADIOLOGY
- Optimized Preload Leakage-Correction Methods to Improve the Diagnostic Accuracy of Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging in Posttreatment Gliomas
- (2009) L.S. Hu et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- The parametric response map is an imaging biomarker for early cancer treatment outcome
- (2009) Craig J Galbán et al. NATURE MEDICINE
- Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment
- (2009) Whitney B. Pope et al. RADIOLOGY
- Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging
- (2009) Ramon F. Barajas et al. RADIOLOGY
- Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements
- (2008) L.S. Hu et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy
- (2008) Suja Saraswathy et al. JOURNAL OF NEURO-ONCOLOGY
- Comparison of Dynamic Susceptibility-weighted Contrast-enhanced MR Methods: Recommendations for Measuring Relative Cerebral Blood Volume in Brain Tumors
- (2008) Eric S. Paulson et al. RADIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search